Master in Biomedical Sciences
-
Schedule
regular course
- ECTS Credits 60
-
<unknown>
Code Name Staff Th.+Ex. Credits/Block 1 2 3 MSBMM100 Master Thesis 22 MSBMM113 Bioethics Ravez Laurent 20h th. 2 MSBMM115 Drug and Society MALONNE HUGUES 12h th. 2 MSBMM101 Pharmacotherapy MALONNE HUGUES MALONNE HUGUES 36h th. 4 MSBMM106 Biopharmaceuticals Masereel Bernard 12h th. 2 MSBMM217 Pharmaco-Economy and Health Technology Assessment ETHGEN OLIVIER 20h th. 2 MSBMM216 Pharmacovigilance Dogne Jean-Michel 20h th. 2 MSBMM107 Biotechnology : Principles and Scale-up Gillet Jean-Pierre 20h th. + 30h ex. 5 MSBMM108 Quality Assurance : GMP, GCP, GLP and Auditing Lienard Patricia 24h th. 3 MSBMM102 Preclinical Drug Development Gillet Jean-Pierre 24h th. + 30h ex. 6 MSBMM103 Clinical Trials Beaudart Charlotte 24h th. + 30h ex. 6 MSBMM104 Statistics Applied to Preclinical and Clinical Studies Le Tallec David 20h th. + 20h ex. 4
-
<unknown>
Code Name Staff Credits Hours/Quarter 1 2 MSBMM100 Master Thesis 22 MSBMM113 Bioethics Ravez Laurent 2 20h th. MSBMM115 Drug and Society MALONNE HUGUES 2 12h th. MSBMM101 Pharmacotherapy MALONNE HUGUES MALONNE HUGUES 4 36h th. MSBMM106 Biopharmaceuticals Masereel Bernard 2 12h th. MSBMM217 Pharmaco-Economy and Health Technology Assessment ETHGEN OLIVIER 2 20h th. MSBMM216 Pharmacovigilance Dogne Jean-Michel 2 20h th. MSBMM107 Biotechnology : Principles and Scale-up Gillet Jean-Pierre 5 20h th. + 30h ex. MSBMM108 Quality Assurance : GMP, GCP, GLP and Auditing Lienard Patricia 3 24h th. MSBMM102 Preclinical Drug Development Gillet Jean-Pierre 6 24h th. + 30h ex. MSBMM103 Clinical Trials Beaudart Charlotte 6 24h th. + 30h ex. MSBMM104 Statistics Applied to Preclinical and Clinical Studies Le Tallec David 4 20h th. + 20h ex.
Admission requirements
Si vous avez un diplôme belge
ACCÈS DIRECT
- bachelier en sciences biomédicales ;
ACCÈS moyennant un éventuel COMPLÉMENT DE 15 CRÉDITS maximum
- bachelier en sciences pharmaceutiques, médecine, médecine vétérinaire, sciences biologiques, sciences dentaires, kinésithérapie et réadaptation, sciences de la motricité, sciences chimiques ;
- master en ingénieur civil en chimie et science des matériaux, sciences de la santé publique, kinésithérapie et réadaptation.
ACCÈS moyennant un COMPLÉMENT DE 15 À 30 CRÉDITS
- bachelier (type court) en sage-femme, infirmier responsable de soins généraux ;
- bachelier de spécialisation (type court) en anesthésie, soins intensifs et aide médicale urgente.
ACCÈS moyennant un COMPLÉMENT DE 30 À 60 CRÉDITS
- bachelier (type court) en diététique, ergothérapie, soins infirmiers, technologie en imagerie médicale, technologue de laboratoire médical ;
- bachelier (type court) en chimie orientation biochimie, biotechnologie, chimie appliquée, environnement;
- bachelier (promotion sociale) en soins infirmiers pour titulaires du brevet d'infirmier hospitalier.
ACCÈS SUR DOSSIER
- autre diplômé de l’enseignement supérieur de la Communauté française de Belgique ;
- diplômé de l’enseignement supérieur hors Communauté française de Belgique;
- sur base de VAE (Valorisation des acquis de l'expérience).
Pour les admissions en master, il y a lieu de prendre contact avec le service des inscriptions.
Si vous avez un diplôme non-belge
If you have a degree from an institution outside of Belgium, you will need to complete and return the admissions request form before 30 September (31 March for students from outside the European Union).
________________________________________________________________________________________________________________
Students with a first degree obtained in Belgium
> DIRECT ACCESS
- Bachelor in Biomedical Sciences.
> ACCESS subject to a maximum of 15 ADDITIONAL CREDITS
- Bachelor in Pharmacy, Medicine, Veterinary Medicine, Biology, Dentistry, Physiotherapy and Rehabilitation, Motor Sciences, Chemistry;
- Master in Chemical and Materials Science Engineering, Public Health, Physiotherapy and Rehabilitation.
> ACCESS subject to AN ADDITIONAL 15 TO 30 CREDITS
- Bachelor in Midwife, Nurse Responsible for General Care;
- Advanced Bachelor in Anaesthesia, Intensive Care and Emergency Medical Aid.
> ACCESS subject to AN ADDITIONAL 30 TO 60 CREDITS
- Bachelor in Dietetics, Occupational Therapy, Nursing, Medical Imaging Technologist, Medical Laboratory Technologist;
- Bachelor in Chemistry orientation Biochemistry, Biotechnology, Applied Chemistry, Environment;
- Bachelor in Nursing for holders of the certificate of Hospital Nurse.
> ACCESS BY APPLICATION
- other higher education qualifications obtained in the French Community of Belgium;
- higher education qualifications obtained outside of the French Community of Belgium;
- on the basis of VAE (‘Valorisation des acquis de l’expérience’ – recognition of previous experience)
For admission to Masters degrees, please contact the Admission Service.
Students with a first degree obtained outside of Belgium
If you have a degree from an institution outside of Belgium, you will need to complete and return the admissions request form before 30 September (31 March for students from outside the European Union): www.unamur.be/en/enrolment
Description
The 60-credit Master lasts one year and provides a basic grounding in Biomedical Sciences, in particular in the field of biopharmaceuticals.
International mobility and openness
Students have the opportunity to spend part of their Master studying abroad, within the context of the Erasmus study programme.
Teaching methods
This Master comprises very few lectures. The emphasis is on interactive learning, via a series of practical and personal projects.
This programme has a particularly professional dimension, with several visits to companies and hospitals, practical projects and a thesis carried out in a laboratory or hospital.
Aims and objectives
- To lead scientific projects which aim for greater understanding of the molecular and cellular mechanisms of pathologies and to improve treatment: to analyse raw data, interpret the results and present observations clearly;
- To master every stage of the development of new therapies, in particular biotechnology- or cell-related therapies;
- To develop biomarkers related to different therapies, for example using genetics and pharmacogenomics;
- To lead and monitor preclinical or clinical trials and to be responsible for the administrative management of testing;
- To ensure the production quality of biotechnological and biosimilar products, cell therapies (stem cells), gene therapies, tissue engineering, medical devices (implants, drug delivery devices, etc.) and so on;
- To monitor the quality, safety and efficiency of a drug before it is placed on the market.
Assessment
In January, students take exams based on the subjects studied during the first semester. In June, students take exams based on the subjects studied in the second semester.
For some subjects, there are regular evaluations based on reports submitted after each session of practical projects. Marks awarded for these practical projects represent a significant percentage of the final marks.